Molecular Medicine in the Service of Mankind: Towards the 2000s

[RG #82] Molecular Medicine in the Service of Mankind: Towards the 2000s

November 1, 2000 - January 31, 2001

Organizer:

Alexander Levitzki (The Hebrew University of Jerusalem)

The group on molecular medicine focused on the role of the new developments in molecular biology and biochemistry in the revolution in medicine which is now taking place. These new developments, including the publication of the human genome, create new opportunities for the improvement of human health. The group's work will concentrate on the ramifications of these technological revolutions for new approaches to the treatment of various cancers and other diseases in which cellular communications fail.

The group will focus primarily on the molecular mechanisms of cell signaling, that is, how cells communicate between themselves and how cells transmit information into the cell. The group will also explore ways to remedy the aberrations in these communication networks which occur in the course of disease. The knowledge of how cell communication works will allow the development of novel therapies.

2000-2001 Research Groups

Members

Anthony Burgess

FELLOW

The Ludwig Institute for Cancer

Anthony is a professor in the Ludwig Institute for Cancer, Melbourne. His research interests are: The molecular mechanisms of signal transduction on the EGF receptor. Within this frame of interest the three dimensional stucture of the EGF receptor ligand TGF has been solved.

David Engelberg

FELLOW

The Hebrew University of Jerusalem

Benjamin Geiger

FELLOW

The Weizmann Institute of Science

Benjamin is a professor in the Department of Molecular Cell Biology at the Weizmann Institute of Science.

Eli Keshet

FELLOW

The Hebrew University of Jerusalem

Eli is a professor in the Department of Molecular Biology at The Hebrew University of Jerusalem.

Alexander Levitzki

FELLOW

The Hebrew University of Jerusalem

Alexander is a professor in the Department of Biological Chemistry at The Hebrew University of Jerusalem.

Wouter Moolenaar

FELLOW

The Netherlands Cancer Institute

Wouter is a professor in the Division of Cellular Biochemistry at the Netherlands Cancer Institute, Amsterdam. His research interests are: cell regulation and signaling by G protein-coupled receptors, particularly those for bioactive lysophospholipids.

Joseph Schlessinger

FELLOW

NYU Medical Center

Joseph is a professor in the Department of Pharmacology at NYU Medical Center. His research interests are: The mechanism of action of receptor tyrosine kinases and analysis of the signaling pathways they activate.